Bernadett Markó

Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone

Katalin Nagy, Bernadett Markó, G. Zsilla et al. · Neurochemical Research · 2010 · 26 citations

Life Sciences, Neuroscience, Pharmacology +16

Neuroprotective and anticonvulsant effects of EGIS‐8332, a non‐competitive AMPA receptor antagonist, in a range of animal models

Gábor Gigler, Krisztina Móricz, Márta Ágoston et al. · British Journal of Pharmacology · 2007 · 21 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Mechanisms underlying the long-term behavioral effects of traumatic experience in rats: The role of serotonin/noradrenaline balance and NMDA receptors

N. Sziray, Cs. Leveleki, György Lévay et al. · Brain Research Bulletin · 2006 · 19 citations

Medicine, Neurobiology, Neuroscience +17

Effects of single and simultaneous lesions of serotonergic and noradrenergic pathways on open-space and bright-space anxiety-like behavior in two animal models

N. Sziray, Zsófia Kuki, Katalin M. Nagy et al. · Behavioural Brain Research · 2010 · 13 citations

Life Sciences, Neurobiology, Neuroscience +17

Effects of 2,3-benzodiazepine AMPA receptor antagonists on dopamine turnover in the striatum of rats with experimental parkinsonism

Katalin Megyeri, Bernadett Markó, N. Sziray et al. · Brain Research Bulletin · 2006 · 11 citations

Life Sciences, Neuroscience, Pharmacology +16